Please ensure Javascript is enabled for purposes of website accessibility
Doctors Try CRISPR Gene Editing for Cancer, a 1st in the US
gvw_ap_news
By Associated Press
Published 6 years ago on
November 6, 2019

Share

The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it’s too soon to know if it will improve survival, doctors reported Wednesday.

“It’s the most complicated genetic, cellular engineering that’s been attempted so far. This is proof that we can safely do gene editing of these cells.” Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia
The doctors were able to take immune system cells from the patients’ blood and alter them genetically to help them recognize and fight cancer, with minimal and manageable side effects.
The treatment deletes three genes that might have been hindering these cells’ ability to attack the disease, and adds a new, fourth feature to help them do the job.
“It’s the most complicated genetic, cellular engineering that’s been attempted so far,” said the study leader, Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia. “This is proof that we can safely do gene editing of these cells.”
After two to three months, one patient’s cancer continued to worsen and another was stable. The third patient was treated too recently to know how she’ll fare. The plan is to treat 15 more patients and assess safety and how well it works.

Chinese Scientists Reportedly Have Tried This for Cancer Patients

“It’s very early, but I’m incredibly encouraged by this,” said one independent expert, Dr. Aaron Gerds, a Cleveland Clinic cancer specialist.

This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Other cell therapies for some blood cancers “have been a huge hit, taking diseases that are uncurable and curing them,” and the gene editing may give a way to improve on those, he said.
Gene editing is a way to permanently change DNA to attack the root causes of a disease. CRISPR is a tool to cut DNA at a specific spot. It’s long been used in the lab and is being tried for other diseases.
This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Chinese scientists reportedly have tried this for cancer patients, but this is the first such study outside that country. It’s so novel that it took more than two years to get approval from U.S. government regulators to try it.
The early results were released by the American Society of Hematology; details will be given at its annual conference in December.

So Far, the Cells Have Survived and Have Been Multiplying as Intended

The study is sponsored by the University of Pennsylvania, the Parker Institute for Cancer Immunotherapy in San Francisco, and a biotech company, Tmunity Therapeutics. Several study leaders and the university have a financial stake in the company and may benefit from patents and licenses on the technology.
Two of the patients have multiple myeloma, a blood cancer, and the third has a sarcoma, cancer that forms in connective or soft tissue. All had failed multiple standard treatments and were out of good options.
Their blood was filtered to remove immune system soldiers called T cells, which were modified in the lab and then returned to the patients through an IV. It’s intended as a one-time treatment. The cells should multiply into an army within the body and act as a living drug.
So far, the cells have survived and have been multiplying as intended, Stadtmauer said.
“This is a brand new therapy” so not it’s not clear how soon any anti-cancer effects will be seen. Following these patients longer, and testing more of them, will tell, he said.

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

UP NEXT

Do Americans Support Trump’s Use of Marines in LA? The Numbers Might Shock You

Clovis Councilmember Basgall Says He Won’t Run for Re-Election

14 hours ago

An Unknowing Fresno County Gave Community Medical $2.7M While Hospital Engaged in Kickback Scheme

15 hours ago

Arizona Governor Vetoes Bill to Ban Teaching Antisemitism in Arizona’s Public Schools

PHOENIX — Arizona Gov. Katie Hobbs has vetoed a proposal that would ban teaching antisemitism at the state’s public K-12 schools, universiti...

12 hours ago

Arizona Democratic Gov. Katie Hobbs, center, applauds for those affected by the Los Angeles area wildfires as she gives the State of the State address in the House of Representatives at the state Capitol with Speaker of the House Rep. Steve Montenegro, R-Litchfield Park, left, and Senate President Warren Petersen, R-Gilbert, flanking the governor on Jan. 13, 2025, in Phoenix. (AP File)
12 hours ago

Arizona Governor Vetoes Bill to Ban Teaching Antisemitism in Arizona’s Public Schools

Rep. LaMonica McIver, D-N.J., demands the release of Newark Mayor Ras Baraka after his arrest while protesting outside an ICE detention prison, May 9, 2025, in Newark, N.J, (AP Photo/Angelina Katsanis, File)
12 hours ago

US Rep. LaMonica McIver Indicted on Federal Charges From Skirmish at New Jersey Immigration Center

President Donald Trump prepares to deliver remarks during a visit to Fort Bragg to mark the U.S. Army anniversary, in North Carolina, U.S., June 10, 2025. REUTERS/Evelyn Hockstein
13 hours ago

US Military Bases to Restore Names Changed After Racial Justice Protests, Trump Says

14 hours ago

Clovis Councilmember Basgall Says He Won’t Run for Re-Election

15 hours ago

An Unknowing Fresno County Gave Community Medical $2.7M While Hospital Engaged in Kickback Scheme

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 5, 2025. REUTERS/Brendan McDermid/ File Photo
16 hours ago

Wall Street Ends Higher as Investors Track Progress of US-China Trade Talks

A bridge crane damaged by Israeli air strikes is pictured in the Red Sea port of Hodeidah, Yemen July 31, 2024. REUTERS/Khaled Abdullah//File Photo
17 hours ago

Israel Strikes Hodeidah Port, Threatens Naval, Air Blockade

U.S. President Donald Trump boards Air Force One as he departs for North Carolina at Joint Base Andrews, Maryland, U.S., June 10, 2025. REUTERS/Evelyn Hockstein
17 hours ago

Trump Warns Protests at Army Parade Will Be Met With Force

Help continue the work that gets you the news that matters most.

Search

Send this to a friend